Blog – tauler smith llp los angeles trial attorneys world j gastrointestinal oncol impact factor

#########

A San Diego Superior Court judge indicated at a Nov. 30 hearing that subpoenas to investors in Puls Technologies would likely go forward in a case dealing with alleged early stage fraud. electricity experiments for 4th graders The underlying lawsuit accuses Puls Technologies Inc., of San Francisco, and its CEO Itai Hirsch of defrauding an early-stage shareholder out of millions of dollars, equivalent to a 5 percent stake in the company. gas outage The court also recently ruled that the lawsuit would go to trial, denying Puls’ and Hirch’s attempt at summary judgment.

Court papers allege that Hirsch was holding secret funding talks with Sequoia CapitaI that were not disclosed to the plaintiff. gas 85 vs 87 The fraud claim alleges that the plaintiff was dismissed from the company under false pretenses just weeks before Puls (then known as Cellsavers and based in San Diego) announced $3 million in funding in December 2015, the lawsuit states. Altogether, Puls has now raised over $90 million in funding, with $50 million just this year coming from multiple sources, including Samsung and Temasek, a holding company owned by the government of Singapore — thus dramatically increasing the value of the plaintiff’s stock, according to the claim.

“It is important that early stage employees who are promised equity obtain full discovery of what was told to future investors about them,” said Robert Tauler, the plaintiff’s Los Angeles attorney. “A lot of startups are financed in the shadows, and individuals who claim they are owed equity are entitled to know about all deals that impact their investment.”

According to the lawsuit, Hirsch kept the funding deal under wraps so that he could keep the plaintiff’s promised equity for himself and his new investors, while taking advantage of the plaintiff’s work — which was crucial in justifying the start-up’s valuation. j gastroenterol hepatol impact factor Though a gamble, work-for-stock deals are not an unusual arrangement in the start-up world, with the potential of owning a valuable equity stake in a successful company.

The ruling by Santa Monica Superior Court Judge Gerald Rosenberg on Oct. 20 means the owners have 20 days to respond to lawsuits accusing them of engaging in unfair competition and false advertising by selling falsely-labeled “all natural” and “safe” male enhancement pills. electricity outage houston tx The Rhino-brand ingredient labels do not list their inclusion of sildenafil – the active ingredient in Viagra.

Tauler represents Houston-based Outlaw Laboratory LP, which makes competing natural products that meet strict FDA dietary supplement regulations. electricity transmission costs Federal law allows competitors to sue retailers for false advertising if products contain secret ingredients. gasbuddy trip The products named in the lawsuit do not disclose the presence of hidden drugs such as sildenafil, tadalafil and dapoxetine on their labels.

C. electricity jokes riddles Kerry Fields, University of Southern California business ethics and product liability expert, told the Santa Monica Mirror in June that businesses selling products containing secret ingredients put themselves in serious legal peril. “There may be a good margin selling those products but it’s not worth the risk because they are representing to the public that their goods are safe… Consumers might sue them as well…,” Fields told the Mirror.